Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Clinical trial NCT00591422 · UNKNOWN
Trial details
- NCT number
- NCT00591422
- Sponsor
- Alaunos Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.